Font Size: a A A
Keyword [neoadjuvant chemoradiotherapy]
Result: 81 - 100 | Page: 5 of 10
81. Neoadjuvant Chemoradiotherapy With Surgery Versus Surgery Alone For Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
82. The Value Of Magnetic Resonance Diffusion Kurtosis Imaging In Early Assessment Of Treatment Response To Neoadjuvant Chemoradiotherapy In Cervical Cancer
83. Analysis Of Recurrence And Survival After Esophagectomy Following Neoadjuvant Therapy In Patients With Locally Advanced Esophageal Squamous Cell Cancer
84. Study On Clinical Related Factors Of Complete Pathological Remission In Locally Advanced Rectal Cancer After Neoadjuvant Radiotherapy And Chemotherapy
85. Clinical Efficacy And Prognostic Factors Of Neoadjuvant Chemoradiotherapy For Locally Advanced Low And Middle Rectal Cancer
86. Clinical Efficacy Of Neoadjuvant Chemoradiotherapy Combined With Surgery For T3N+/T4Nx Rectal Cancer
87. Effect Of Neoadjuvant Chemoradiotherapy On The Expression Of PD-1/PD-L1 In Rectal Cancer
88. Meta-analysis For The Therapeutic Effect And Safety Of Neoadjuvant Chemoradiotherapy In Resectable Esophageal Cancer
89. Advances In Neoadjuvant Therapy For Locally Advanced Esophageal Cancer
90. Predictive Value Of Blood Inflammation Cell Ratios For Pathologic Complete Response In Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
91. Efficacy Of Aspirin As An Adjuvant Aget During Neoadjuvant Chemoradiotherapy For Rectal Cancer :A Meta-analysis
92. The P53 Protein Expression And Its Association With The Recent Curative Effect After Neoadjuvant Chemoradiotherapy In Rectal Cancer
93. Meta-analysis Of Neoadjuvant And Postoperative Chemoradiotherapy For Resectable Esophageal Cancer
94. Clinical Efficacy And Prognosis Of Long-course Neoadjuvant Chemoradiotherapy For Locally Advanced Rectal Cancer
95. Meta Analysis Of Clinical Efficacy Of Preoperative Neoadjuvant Chemoradiotherapy Combined With TME In The Treatment Of Middle And Low Rectal Cancer
96. Predictive Value Of IVIM And DKI In Patients With Cervical Cancers Treated With Neoadjuvant Chemoradiotherapy
97. Association Analysis Of MrTRG And Prognosis In Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
98. Neoadjuvant Chemoradiotherapy For Rectal Cancer:Causes Of Anastomotic Leakage After Dixon And The Necessity Of Preventive Stoma
99. CapeOx In Preoperative Concurrent Chemoradiotherapy For Locally Advanced Rectal Cancer Compared The Efficacy And Adverse Reactions Of Xeloda
100. Clinical Analysis Of The Interval Between Neoadjuvant Chemoradiotherapy And Surgery For Esophageal Cancer
  <<First  <Prev  Next>  Last>>  Jump to